Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-65
SponsorUniversity of Washington

About this trial

Spinal cord injury (SCI) can make it hard for the body to self-regulate some of its automatic functions like blood pressure, breathing, and heart rate. This can also make it hard for those living with SCI to exercise or complete their usual daily activities. The goal of this randomized trial is to test combinatory therapy of moderate arm-crank exercise paired with non-invasive transcutaneous spinal cord stimulation (tSCS) for cardiovascular recovery in adults aged 21-65 following chronic motor-complete spinal cord injury (SCI) at or above the thoracic sixth spinal segment (≥T6).

The main questions the study aims to answer are:

* Conduct tSCS mapping to determine the most effective location and stimulation intensity for BP control in individuals with motor-complete SCI ≥ T6. * Evaluate the effects 8 weeks of targeted tSCS paired with arm-crank exercise compared to sham stimulation with exercise on improving cardiovascular function in individuals with motor-complete SCI ≥T6. * Evaluate the dosage-response of 8 weeks vs. 16 weeks of targeted tSCS paired with arm-crank exercise on cardiovascular function in individuals with motor-complete SCI ≥T6. * Explore the mechanisms involved in cardiovascular recovery with long-term tSCS paired with arm-crank exercise.

Participants will:

* Receive either transcutaneous spinal cord stimulation or "sham" spinal cord stimulation while exercising on an arm-crank bicycle in the first 8 weeks. * Come in for approximately 60 visits over a 6-month period. This includes 2, 8-week periods where the investigators will ask participants to come in 3x per week for spinal cord stimulation and exercise. * During assessment visits the researchers will perform a variety of exams including a neurologic, cardiovascular, pulmonary, physical, and autonomic exam, and will ask questions about quality of life and functioning. Assessment procedures also include stool sample and nasal swab collection.

Researchers will compare those who receive tSCS and do moderate arm-crank exercise to those who receive a sham stimulation and do moderate arm-crank exercise to see if tSCS is effective at improving cardiovascular and autonomic functioning in those with SCI.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Are between 21-65 years of age.

Chronic SCI (non-progressive, with complete motor paralysis) at or above the T6 spinal cord segment.

Greater than ten months post injury or diagnosis, at least 6 months from any spinal surgery.

American Spinal Injury Association Impairment Scale (AIS) A, B for SCI.

Disqualifiers

Have autoimmune etiology of spinal cord dysfunction/injury

Have history of additional neurologic disease, such as stroke, MS, traumatic brain injury, etc.

Have peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc.)

Have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcutaneous Spinal Cord Stimulation

    Device

    Non-invasive electrical stimulation of the spinal cord over the skin

  • Arm-crank bike exercise

    Behavioral

    Exercise using an arm-bike to target cardiovascular functioning.

  • Sham Stimulation

    Other intervention

    Non-invasive electrical stimulation of a lower extremity muscle group over the skin.

Treatment groups

16 Participants
are divided into 2 treatment groups
Group A: tSCS paired with arm-crank exerciseExperimental treatment 2 interventions
Group B: Sham stimulation paired with arm-crank exerciseSham comparator 3 interventions

Trial outcomes

Primary outcomes

1

Change in systolic Blood Pressure (BP) from baseline.

Continuous beat-by-beat BP will be measured using a finger photoplethysmography.

Time frame
Baseline
2

Change in systolic Blood Pressure during a sit-up test or head-up tilt test.

Continuous beat-by-beat BP will be measured during a orthostatic challenge.

Time frame
Repeated measurements before and after each 8 week-intervention block, an average of 6 months
3

Heart rate variability recorded by electrocardiogram (ECG).

Parameters using RR intervals (R-wave peak to R-wave peak in electrocardiogram) processed to assess the activity of autonomic nervous system.

Time frame
Repeated measurements before and after each 8 week-intervention block, an average of 6 months

Secondary outcomes

1

Peak oxygen uptake (VO2peak)

Measured during incremental cardiopulmonary exercise test (CPET) on the arm-crank.

Time frame
Repeated measurements before and after each 8 week-intervention block, an average of 6 months
2

Autonomic dysfunction following Spinal Cord Injury (ADFSCI) measure

The Autonomic Dysfunction following SCI (ADFSCI) measure will be used to assess severity and frequency of autonomic dysreflexia. Greater scores equal greater frequency of autonomic dysfunction, ranging from 0 (never) to 4 (very often) for each item.

Time frame
Repeated measurements before and after each 8 week-intervention block, an average of 6 months
3

International Standards for Neurological Classification of Spinal Cord Injury

level and severity of damage to motor and sensory pathways will be determined by trained clinicians. Pin prick and light touch will be done by researchers on participant's left and right side. Check marks are given for each prick or touch that is felt by the participant, then tallied. Scores range from 0-56 for both the Left and Right side of the body, and 0-112 for the total score. High scores represent greater sensory functioning.

Time frame
Repeated measurements before and after each 8 week-intervention block, an average of 6 months
4

International Standards to document remaining Autonomic Function after Spinal Cord Injury (ISAFSCI)

Scores for questions on the ISAFSCI range from 0 to 2, with 0 representing complete loss of control and 2 representing normal functioning. Lower scores equal worse health functioning.

Time frame
Repeated measurements before and after each 8 week-intervention block, an average of 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.